Chapman, B. C., Gleisner, A., Rigg, D., Messersmith, W., Paniccia, A., Meguid, C., . . . Edil, B. H. (2018). Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma. JOP.
Style de citation ChicagoChapman, Brandon C., et al. "Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX Versus Gemcitabine Abraxane in Patients With Pancreatic Adenocarcinoma." JOP 2018.
Style de citation MLAChapman, Brandon C., et al. "Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX Versus Gemcitabine Abraxane in Patients With Pancreatic Adenocarcinoma." JOP 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.